Compare CACC & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CACC | ALKS |
|---|---|---|
| Founded | 1972 | 1987 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 4.8B |
| IPO Year | 1992 | 1991 |
| Metric | CACC | ALKS |
|---|---|---|
| Price | $460.74 | $28.89 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 13 |
| Target Price | ★ $465.00 | $42.85 |
| AVG Volume (30 Days) | 103.2K | ★ 2.4M |
| Earning Date | 01-29-2026 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 151.44 | 2.44 |
| EPS | ★ 37.89 | 2.02 |
| Revenue | $1,232,900,000.00 | ★ $1,521,338,000.00 |
| Revenue This Year | $129.15 | N/A |
| Revenue Next Year | $1.97 | $24.22 |
| P/E Ratio | ★ $12.16 | $14.10 |
| Revenue Growth | ★ 45.72 | 1.08 |
| 52 Week Low | $401.90 | $25.17 |
| 52 Week High | $560.00 | $36.45 |
| Indicator | CACC | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 52.87 | 43.07 |
| Support Level | $448.94 | $28.96 |
| Resistance Level | $474.68 | $29.80 |
| Average True Range (ATR) | 14.60 | 0.88 |
| MACD | 4.08 | 0.01 |
| Stochastic Oscillator | 78.23 | 35.76 |
Credit Acceptance Corp is a consumer finance company that specializes in automobile loans. These loans are offered through a U.S. nationwide network of automobile dealers that benefit from sales of vehicles to consumers who could otherwise not obtain financing. The company also benefits from repeat and referral sales, and from sales to customers responding to advertisements for financing, but qualify for traditional financing. The company derives its revenue from finance charges, premiums earned on the reinsurance of vehicle service contracts, and other fees. Of these, financing charges, including servicing fees, are by far a source of revenue.
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.